HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful liver, kidney, and pancreas transplantation from a donor with cerebral emboli from a left atrial myxoma.

Abstract
Although transmission and engraftment of donor-derived malignancies is rare in recipients of solid organ transplants, it is associated with unfavorable allograft and patient survival. Therefore, a recent history of malignancy is considered a contraindication to organ donation. Although atrial myxomas are benign cardiac tumors of stromal origin, they can lead to systemic embolization with ectopic myxoma formation. We report successful liver, kidney, and pancreas transplantation into 3 recipients from a donor with cerebral emboli from a left atrial myxoma. Eighteen months after transplantation, all 3 patients enjoy good allograft function and are free of donor-derived atrial myxoma. Although the duration of follow-up in this report is limited, we suggest that the presence of atrial myxoma should not be viewed as an absolute contraindication to organ recovery, particularly in view of the shortage of organ donors and the attendant morbidity and mortality for patients on waiting lists.
AuthorsR J Canter, P L Abt, L A Litzky, A Frank, A B Abt, M T Sellers, J F Markmann, K M Olthoff, A Naji, A Shaked
JournalTransplantation proceedings (Transplant Proc) Vol. 37 Issue 10 Pg. 4334-6 (Dec 2005) ISSN: 0041-1345 [Print] United States
PMID16387113 (Publication Type: Case Reports, Journal Article)
Topics
  • Adolescent
  • Heart Atria (pathology)
  • Hepatectomy
  • Humans
  • Intracranial Embolism
  • Kidney Transplantation
  • Liver Transplantation
  • Male
  • Myxoma (pathology)
  • Nephrectomy
  • Pancreas Transplantation
  • Pancreatectomy
  • Tissue Donors (statistics & numerical data)
  • Tissue and Organ Harvesting (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: